Compugen Ltd
Compugen Ltd logo
CGEN

Compugen Ltd (CGEN)

$1.216.5%

Market is closed
– opens on 8 PM, 01 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$1.0
Day's Range
$1.22
$0.51
52-Week Range
$4.88
1 month return15.38%
3 month return4.35%
1 year return72.22%
5 year return51.02%

Company Information

Compugen is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable, predictive computational discovery platforms to identify novel drug targets and develop therapeutics in the field of cancer immunotherapy. The Company's lead product candidate, COM701, a first-in-class anti-PVRIG antibody, for the treatment of solid tumors, is undergoing a Phase 1 clinical study. In addition, COM902, Compugen's antibody targeting TIGIT, is expected to enter the clinic in early 2020. The Company's therapeutic pipeline also includes early-stage immuno-oncology programs focused largely on myeloid targets. Compugen's business model is to selectively enter into collaborations for its novel targets and related drug product candidates at various stages of research and development. The Company is headquartered in Israel, with offices in South San Francisco, CA.
OrganizationCompugen Ltd
Employees73
CEODr. Anat Cohen-Dayag Ph.D.
IndustryHealth Technology

Analyst Recommendation

based on 7 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 7 Wall street analysts offering stock ratings for Compugen Ltd(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 424.17%

Current

$1.2

Target

$6.29

Recommendation Trend

Based on 7 analyst

Current1M Ago3M Ago
Buy
7
11
12
Hold
0
2
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
89.2M
Book Value
$0.92
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-0.4
PEG Ratio
0.0
Wall Street Target Price
6.29

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
1.12
Enterprise Value
1.2M
Enterprise Value/Revenue
294.9
Enterprise Value/Ebitda
-0.03

Technicals

Beta
2.41
50 Day MA
0.83
200 Day MA
1.81

Discover more

Frequently Asked Questions

What is Compugen Ltd share price today?

Can Indians buy Compugen Ltd shares?

How can I buy Compugen Ltd shares from India?

Can Fractional shares of Compugen Ltd be purchased?

What are the documents required to start investing in Compugen Ltd stocks?

What are today’s High and Low prices of Compugen Ltd?

What are today’s traded volumes of Compugen Ltd?

What is today’s market capitalisation of Compugen Ltd?

What is the 52 Week High and Low Range of Compugen Ltd?

How much percentage Compugen Ltd is down from its 52 Week High?

How much percentage Compugen Ltd is up from its 52 Week low?

What are the historical returns of Compugen Ltd?

Who is the Chief Executive Officer (CEO) of Compugen Ltd?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*